Surface Oncology, Inc. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales AgreementSurface Oncology, Inc. • May 1st, 2019 • Biological products, (no disgnostic substances) • New York
Company FiledMay 1st, 2019 Industry JurisdictionSurface Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JONESTRADING INSTITUTIONAL SERVICES LLC (the “Agent”), as follows: